67 related articles for article (PubMed ID: 30293322)
1. [Association between AOX1, IRF4 methylation in peripheral blood leukocyte DNA and the risks of breast cancer: a case-control study].
Zhang H; Liu YP; Ge AQ; Wang X; Sun HR; Bi HR; Pang D; Zhao YS
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Sep; 39(9):1265-1269. PubMed ID: 30293322
[No Abstract] [Full Text] [Related]
2. DNA Methylation-Mediated Lowly Expressed AOX1 Promotes Cell Migration and Invasion of Prostate Cancer.
Wu J; Wei Y; Li T; Lin L; Yang Z; Ye L
Urol Int; 2023; 107(5):517-525. PubMed ID: 35354150
[TBL] [Abstract][Full Text] [Related]
3. Methylation of WT1, CA10 in peripheral blood leukocyte is associated with breast cancer risk: a case-control study.
Ge A; Gao S; Liu Y; Zhang H; Wang X; Zhang L; Pang D; Zhao Y
BMC Cancer; 2020 Jul; 20(1):713. PubMed ID: 32736539
[TBL] [Abstract][Full Text] [Related]
4. DUSP1 promoter methylation in peripheral blood leukocyte is associated with triple-negative breast cancer risk.
Li J; Chen Y; Yu H; Tian J; Yuan F; Fan J; Liu Y; Zhu L; Wang F; Zhao Y; Pang D
Sci Rep; 2017 Feb; 7():43011. PubMed ID: 28220843
[TBL] [Abstract][Full Text] [Related]
5. Effect of genetic ancestry on leukocyte global DNA methylation in cancer patients.
Cappetta M; Berdasco M; Hochmann J; Bonilla C; Sans M; Hidalgo PC; Artagaveytia N; Kittles R; Martínez M; Esteller M; Bertoni B
BMC Cancer; 2015 May; 15():434. PubMed ID: 26012346
[TBL] [Abstract][Full Text] [Related]
6. Methylation of a panel of genes in peripheral blood leukocytes is associated with colorectal cancer.
Luo X; Huang R; Sun H; Liu Y; Bi H; Li J; Yu H; Sun J; Lin S; Cui B; Zhao Y
Sci Rep; 2016 Jul; 6():29922. PubMed ID: 27453436
[TBL] [Abstract][Full Text] [Related]
7. Association of peripheral blood leukocyte KIBRA methylation with gastric cancer risk: a case-control study.
Zhang Y; Zhou H; Sun H; Chen J; Huang D; Han X; Ren X; Lin S; Fan Q; Tian W; Zhao Y
Cancer Med; 2018 Jun; 7(6):2682-2690. PubMed ID: 29659170
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
[TBL] [Abstract][Full Text] [Related]
9. Association of physical activity and polymorphisms in FGFR2 and DNA methylation related genes with breast cancer risk.
Xi J; Su Y; Beeghly Fadiel A; Lin Y; Su FX; Jia WH; Tang LY; Ren ZF
Cancer Epidemiol; 2014 Dec; 38(6):708-14. PubMed ID: 25270516
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation markers panel can improve prediction of response to neoadjuvant chemotherapy in luminal B breast cancer.
Sigin VO; Kalinkin AI; Kuznetsova EB; Simonova OA; Chesnokova GG; Litviakov NV; Slonimskaya EM; Tsyganov MM; Ibragimova MK; Volodin IV; Vinogradov II; Vinogradov MI; Vinogradov IY; Kutsev SI; Strelnikov VV; Zaletaev DV; Tanas AS
Sci Rep; 2020 Jun; 10(1):9239. PubMed ID: 32514046
[TBL] [Abstract][Full Text] [Related]
11. Association between global DNA hypomethylation in leukocytes and risk of breast cancer.
Choi JY; James SR; Link PA; McCann SE; Hong CC; Davis W; Nesline MK; Ambrosone CB; Karpf AR
Carcinogenesis; 2009 Nov; 30(11):1889-97. PubMed ID: 19584139
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin specific peptidase 4 stabilizes interferon regulatory factor protein and promotes its function to facilitate interleukin-4 expression in T helper type 2 cells.
Guo Z; Xu P; Ge S; Zhang C; Zheng X; Xu J; Liu Z; Li B; Ge S
Int J Mol Med; 2017 Oct; 40(4):979-986. PubMed ID: 28791349
[TBL] [Abstract][Full Text] [Related]
13. Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer.
Severi G; Southey MC; English DR; Jung CH; Lonie A; McLean C; Tsimiklis H; Hopper JL; Giles GG; Baglietto L
Breast Cancer Res Treat; 2014 Dec; 148(3):665-73. PubMed ID: 25407397
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation.
Iwamoto T; Yamamoto N; Taguchi T; Tamaki Y; Noguchi S
Breast Cancer Res Treat; 2011 Aug; 129(1):69-77. PubMed ID: 20882403
[TBL] [Abstract][Full Text] [Related]
15. Polycyclic aromatic hydrocarbon (PAH)-DNA adducts and breast cancer: modification by gene promoter methylation in a population-based study.
White AJ; Chen J; McCullough LE; Xu X; Cho YH; Teitelbaum SL; Neugut AI; Terry MB; Hibshoosh H; Santella RM; Gammon MD
Cancer Causes Control; 2015 Dec; 26(12):1791-802. PubMed ID: 26407953
[TBL] [Abstract][Full Text] [Related]
16. No difference in the frequency of locus-specific methylation in the peripheral blood DNA of women diagnosed with breast cancer and age-matched controls.
Wojdacz TK; Thestrup BB; Cold S; Overgaard J; Hansen LL
Future Oncol; 2011 Dec; 7(12):1451-5. PubMed ID: 22112320
[TBL] [Abstract][Full Text] [Related]
17. Correlation between global methylation level of peripheral blood leukocytes and serum C reactive protein level modified by MTHFR polymorphism: a cross-sectional study.
Nojima M; Iwasaki M; Kasuga Y; Yokoyama S; Onuma H; Nishimura H; Kusama R; Yoshida T; Tsugane S
BMC Cancer; 2018 Feb; 18(1):184. PubMed ID: 29439678
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood.
Yang R; Pfütze K; Zucknick M; Sutter C; Wappenschmidt B; Marme F; Qu B; Cuk K; Engel C; Schott S; Schneeweiss A; Brenner H; Claus R; Plass C; Bugert P; Hoth M; Sohn C; Schmutzler R; Bartram CR; Burwinkel B
Int J Cancer; 2015 Apr; 136(8):1845-55. PubMed ID: 25213452
[TBL] [Abstract][Full Text] [Related]
19. A Systematic Analysis of the Relationship of CDH13 Promoter Methylation and Breast Cancer Risk and Prognosis.
Yang J; Niu H; Huang Y; Yang K
PLoS One; 2016; 11(5):e0149185. PubMed ID: 27153114
[TBL] [Abstract][Full Text] [Related]
20. White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO).
Sturgeon SR; Pilsner JR; Arcaro KF; Ikuma K; Wu H; Kim SM; Chopra-Tandon N; Karpf AR; Ziegler RG; Schairer C; Balasubramanian R; Reckhow DA
Breast Cancer Res; 2017 Aug; 19(1):94. PubMed ID: 28821281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
